30 months follow-up of an early enzyme replacement therapy in a severe Morquio A patient: About one case

Patients under 5 years were not evaluated in the phase-3 study for enzyme replacement therapy (ERT) in MPS IV A. Here we describe the evolution of a severe Morquio A pediatric patient who was diagnosed at 19 months old and treated by ERT at 21 months old for the next 30 months. Applying the standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Do Cao, J., Wiedemann, A., Quinaux, T., Battaglia-Hsu, S.F., Mainard, L., Froissart, R., Bonnemains, C., Ragot, S., Leheup, B., Journeau, P., Feillet, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065040/
https://www.ncbi.nlm.nih.gov/pubmed/27761411
http://dx.doi.org/10.1016/j.ymgmr.2016.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065040/
https://www.ncbi.nlm.nih.gov/pubmed/27761411
http://dx.doi.org/10.1016/j.ymgmr.2016.10.001

Ejemplares similares